Home LiteratureArticle Details
PMID: 2514148 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Intrinsic differences in the transplantability and outgrowth potential of DMBA-induced rat mammary tumors.

International journal of cancer ·Vol. 44 ·No. 6 ·1989-12-15 ·Pages 1048-51

Rivera EM, Alston-Mills B

Abstract

Only a small proportion of DMBA-induced rat mammary tumors are transplantable in cleared (gland-free) mammary fat pads. To enhance their transplantability, several host factors were modified: age, parity, hormone levels, and tissue integrity of the fat pad. Our 2 important findings were that (1) there were individual differences between the tumors in their transplantability and potential to proliferate normal and hyperplastic outgrowths, and (2) these differences were determined by their inherent potential and not by their environment. These intrinsic differences among the tumors are consistent with the concept that properties of a given type of tumor are independently variable.

MeSH Terms
9,10-Dimethyl-1,2-benzanthracene Age Factors Animals Cell Division/drug effects Estrogens/pharmacology Female Mammary Glands, Animal/pathology Mammary Neoplasms, Experimental/pathology Ovariectomy Parity Progesterone/pharmacology Rats Rats, Inbred Lew
Chemicals
Estrogens Progesterone 9,10-Dimethyl-1,2-benzanthracene
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rivera E M
Department of Zoology, Michigan State University, East Lansing 48823-1115.
Alston-Mills B
Article Info
Journal
International journal of cancer
Abbr.
Int J Cancer
ISSN
0020-7136
Published
1989-12-15
Pages
1048-51
Language
English
Region
United States
NLM ID
0042124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com